HOME > Events > 詳細

                   
2024/04/25

discovery of stanniocalcin1 as cardiotoxic defence gene

We have discovered stanniocalcin1 as cardiotoxic defence gene in 2015. the potential clinical applications of stanniocalcin in oncocardiology include its use as a biomarker for cancer therapy-induced cardiotoxicity, its potential as a therapeutic target for cardioprotection, and its role in regulating calcium homeostasis, which may be relevant for managing calcium-related cardiovascular complications in cancer patients.

関連ファイル

discovery of stanniocalcin1 as cardiotoxic defence gene

high-throughput screening for cardiotoxicology

関連リンク

三重大学大学院医学系研究科システムズ薬理学

三重大学メディカルゼブラフィッシュ研究センター